Press release
Global Diabetic Neuropathy Market to 2025| Johnson & Johnson, Boehringer Ingelheim GmbH, NeuroMetrix, Eli Lilly and Company, GlaxoSmithKline, Pfizer, Lupin, Astellas Pharma, Depomed
Global Diabetic Neuropathy Market: Overview
The report on diabetic neuropathy market analyzes the current and future scenario of the global market. Increase in prevalence of diabetic neuropathy, advent of new therapeutics for treatment of neuropathy, favorable reimbursement scenario, and investment from key players in development of cost effective therapeutics for diabetic neuropathy are the major drivers of the global diabetic neuropathy market.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=197308
The diabetic neuropathy market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global diabetic neuropathy market with respect to the segments based on disorder type, treatment type, distribution channel and geography.
A detailed qualitative analysis of drivers and restraints of the market and its opportunities has been provided in the market overview section. In addition, the section comprises Porter’s five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global diabetic neuropathy market.
Global Diabetic Neuropathy Market: Segmentation
Based on disorder type, the diabetic neuropathy market is segmented as peripheral neuropathy, autonomic neuropathy, proximal neuropathy, focal neuropathy. The disorder type market segments have been analyzed based on available approved treatment for disorders and patient data. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on treatment type, diabetic neuropathy market is segmented into drugs, radiotherapy and physiotherapy. The drug segment is further segmented into analgesic, antidepressant, anticonvulsant drugs and other drugs. The analgesic segment is further segmented into topical, opioid, NSAIDs. The antidepressant segment is segmented into TCAs, SNRIs, and SSRIs. Radiotherapy segment is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), others.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/diabetic-neuropathy-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html/toc
The market segments have been extensively analyzed based on demand for available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Diabetic Neuropathy Market: Regional Analysis
Geographically, the global diabetic neuropathy market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa).
The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Global Diabetic Neuropathy Market: Competitive Analysis
The report also profiles major players in the global diabetic neuropathy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include – Johnson & Johnson (Janssen Global Services, LLC), Boehringer Ingelheim GmbH, NeuroMetrix, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Pfizer, Inc., Lupin Limited, Astellas Pharma Inc., Glenmark Pharmaceuticals Ltd, Arbor Pharmaceuticals, LLC, Depomed, Inc., and others.
The Global Diabetic Neuropathy Market is segmented as given below:
Global Diabetic Neuropathy Market, by Product
Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy
Global Diabetic Neuropathy Market, by Treatment Type
Drug
Analgesic
Topical
Capsaicin
Others
Opioids
Morphine
Others
NSAIDs
Ibuprofen
Naproxen
Others
Antidepressant
TCAs
Amitriptyline
Imipramine
Others
SNRIs
Duloxetine
Others
SSRIs
Citalopram
Paroxetin
Others
Anticonvulsants
Gabapentin
Pregabalin
Topimarate
Others
Other Drugs
Radiotherapy
TENS
Others
Physiotherapy
Global Diabetic Neuropathy Market, by Distribution Channel
Hospitals
Clinics
Retail Pharmacy
Online Pharmacy
Global Diabetic Neuropathy Market, by Geography
North America
US
Canada
Europe
Germany
U.K.
Russia
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
India
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=197308
Rest of Latin America
Middle East & Africa
GCC countries
South Africa
Rest of Middle East & Africa
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket Ghumare,
ResearchMoz,
90 State Street, Albany NY, United States,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Follow me on : https://marketinfo247.wordpress.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Diabetic Neuropathy Market to 2025| Johnson & Johnson, Boehringer Ingelheim GmbH, NeuroMetrix, Eli Lilly and Company, GlaxoSmithKline, Pfizer, Lupin, Astellas Pharma, Depomed here
News-ID: 1469925 • Views: …
More Releases from Diabetic Neuropathy Market
Future of Diabetic Neuropathy Market in Global Industry : Market Attractiveness, …
Albany, NY,19th January : Recent research and the current scenario as well as future market potential of "Diabetic Neuropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" globally.
The report on diabetic neuropathy market analyzes the current and future scenario of the global market. Increase in prevalence of diabetic neuropathy, advent of new therapeutics for treatment of neuropathy, favorable reimbursement scenario, and investment from key…
Diabetic Neuropathy Market - Global Industry Analysis 2024
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population…
Diabetic Neuropathy Market - Global Industry Analysis 2025
Market Overview
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic…
Diabetic Neuropathy Market — Global Industry Insights, Trends, Outlook, and Op …
Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population…
More Releases for Rest
An APIOps Platform , REST API Development
The pandemic's pandemonium served as a lesson in the value of adaptability, composability, and flexibility for both organizations and their ingrained technologies. Additionally, the rapid digitization of the world has made international connectivity more crucial than ever. Both of these domains benefit from API technology, which will make them even more crucial over the coming year. The user experience, centralization, and automated delivery of new APIs with integrated testing, security,…
Livpure Launches Back Rest Cushion
Livpure Sleep is one the flagship brands of the SAR group. A company with a fast-paced growth in corporate India and a valued legacy, Livpure has swooped the sleeping solutions market and with a wide range of smart and innovative products. Livpure understands consumer’s need for comfort and sleep. Livpure, a manufacturer of water purifiers, air conditioners, air coolers, air purifiers, and other home-focused smart solutions, has jumped into the…
Compart Goes REST API
DocBridge© Pilot 3.8, the new version of the output management software for cost-optimized Omnichannel customer communication, is now available. The most important innovation of the current release is an open programming interface based on the REST technology (API), which allows the user an even better integration of DocBridge© Pilot into his existing document and output management structures.
Without time-consuming scripting, functions and data of DocBridge© Pilot can be retrieved via URLs…
Agrochemicals Market in Rest of World
ReportsWorldwide has announced the addition of a new report title Rest of World: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports.
The report “Rest of World: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG)…
Rest Room Courtesy Is Still Appreciated
Respecting strangers is common courtesy; at least it should be. Kudos to those who respects others’.
Historically, restroom courtesy has been engrained in ethics of social responsibility. After all, since grade school, most people have learned the value of picking up behind themselves, when using public rest rooms.
Yet unfortunately, there are still countless people who lack rest room courtesy.
As a commercial cleaning and building maintenance service provider, too often, Allen Maintenance…
Savvy Rest Is Now GOTS Certified
May 25, 2011, Charlottesville, Virginia -- Savvy Rest, Central Virginia manufacturer of organic mattresses and bedding, is now a GOTS-certified company. GOTS stands for Global Organic Textile Standard, and it means that Savvy Rest’s manufacturing facility has passed the most demanding organic requirements a product or manufacturer can meet. GOTS certification ensures that organic textiles have been responsibly harvested, manufactured and labeled.
“While any business can sell products that contain some…
